Research & Development

The Research & Development team at Crescendo Biologics is dedicated to advancing innovative biopharmaceuticals focused on enhancing T cell therapies, particularly through the modulation of CD137. This multidisciplinary team works on various stages of therapeutic development, including discovery, process development, and translational biology, to ensure the effective design, formulation, and clinical application of conditionally-activated T cell platforms. Their collaborative efforts aim to translate cutting-edge scientific discoveries into viable treatment options for patients.